Navigation Links
Sangamo BioSciences Reports Third Quarter 2011 Financial Results
Date:10/25/2011

gher expenses for our HIV/AIDS program.  General and administrative expenses were $3.6 million for the third quarter of 2011, compared to $2.9 million for the same period in 2010. The increase was primarily due to increased professional services expenses.

Total operating expenses for the third quarter of 2011 were $11.4 million, compared to $11.7 million for the same period in 2010.  

Nine Months ResultsFor the nine months ended September 30, 2011, the consolidated net loss was $29.4 million, or $0.59 per share, compared to a consolidated net loss of $16.5 million, or $0.37 per share, for the nine months ended September 30, 2010.  Revenues were $5.6 million for the nine months of 2011, compared to $16.1 million in the same period in 2010, with the decrease primarily due to the completion, in July 2010, of the amortization period for the commercial and research license fee received from Sigma under the expanded agreement of October 2009. Total operating expenses were $35.0 million for the nine months of 2011 and $32.7 million for the same period in 2010.

Financial Guidance

  • Cash, cash equivalents and marketable securities of at least $85 million at the end of 2011, exclusive of new funding from potential future partnerships.
  • Operating expenses for 2011 to be relatively flat compared to 2010, in the range of $43 to $47 million.
  • Revenues and related cash proceeds in the range of $10 to $12 million in 2011.

  • Recent Events

  • Announcement that Sangamo's Phase 2b Trial (SB-509-901) in Subjects with Moderately Severe Diabetic Neuropathy Did Not Meet Key Endpoints. Based on the data, the Company announced that it has discontinued further development of SB-509 and will focus resources on its pipeline including ZFP Therapeutics for HIV and monogenic diseases.
  • Presentation at ICAAC 2011 of Groundbreaking Clinical Data from Sangamo's Ongoing Phase 1 Clinical Trials
    '/>"/>

  • SOURCE Sangamo BioSciences, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Sangamo BioSciences Announces Third Quarter 2011 Conference Call and Webcast
    2. Sangamo BioSciences Announces Presentation at the 18th Annual Newsmakers in the Biotech Industry Conference
    3. Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference
    4. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
    5. Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology
    6. Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast
    7. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
    8. Sangamo Announces Pricing of Public Offering of Common Stock
    9. Sangamo Announces Public Offering of Common Stock
    10. Sangamo BioSciences and CHDI Foundation Announce Collaboration to Develop ZFP Therapeutic® for Huntingtons Disease
    11. Sangamo BioSciences Announces Presentation at the 10th Annual Needham Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... (PRWEB) July 31, 2014 Sales Horizons, ... of its online sales training course – Mastering ... their sales performance. , Drawn from proven sales training ... companies, Mastering the Complex Sale online sales training course ... anyone who has face-to-face contact with customers, like technical ...
    (Date:7/30/2014)... and PARIS , July 30, 2014 ... SAN and NYSE: SNY) today announced that the Companies ... (FDA) rare pediatric disease priority review voucher in connection ...  The priority review voucher entitles the holder to designate ... expedited 6-month review from the filing date instead of ...
    (Date:7/30/2014)... 2014  Decision Resources Group finds that the ... the United States believe ... will be the level of savings achievable by ... lower cost to patients. Payers plan to leverage ... pricing expectations in order to encourage physician prescribing ...
    (Date:7/30/2014)... -- The Chicago Bears are excited to announce the team,s ... an effort to raise awareness of skin cancer. Through ... me™ skin cancer screenings at a preseason fan event ... SPOT me™ is an educational campaign designed to inform the ... skin cancer, and encourages people to get screened by ...
    Breaking Biology Technology:Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4
    ... 6 Biocept, Inc. ("Biocept"), an,emerging leader in biotechnology, ... CEO, President and Director and the appointment,of Edward A. ... its former CEO, President and Director, Gordon F. Janko., ... highly regarded professional,in our field, and believe he is ...
    ... many genes encoding proteins that are similar to those of ... only a small fraction the genome, and there are many ... are these sequences doing, and do we really need them ... Genome Research ( www.genome.org ), researchers have delved ...
    ... Sciences,Holdings, Inc. (Nasdaq: ADLS ), today announced ... Department informed the Company that the,market value of ... 10,consecutive days, which is the requirement for continued ... Rule 4310(c)(3)(B). Nasdaq,also informed the Company that it ...
    Cached Biology Technology:Biocept, Inc. Announces CEO and Director Appointments 2Use it or lose it? Researchers investigate the dispensability of our DNA 2Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 2Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 3
    (Date:7/30/2014)... is paving the way for a breakthrough that ... troops exposed to poisonous chemicalsparticularly those in pesticides ... the current issue of the journal ChemBioChem ... are compounds commonly used in pesticides and warfare ... School of Engineering Associate Professor of Chemical and ...
    (Date:7/30/2014)... the potential effects of climate change on the ... the wrong factors, according to a new paper ... Society, University of Queensland, and other organizations. The ... is missing the point when it comes to ... climate change scientists focus on the "direct" threats ...
    (Date:7/30/2014)... (OUP) is pleased to announce its new relationship with ... OUP and CINP will partner to publish International ... fully open-access journal. , Alan Frazer, Editor-in-Chief of ... and expertise of OUP will further facilitate the goal ... the very leading journals within neuropsychopharmacology. The conversion of ...
    Breaking Biology News(10 mins):Engineering a protein to prevent brain damage from toxic agents 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2OUP to partner with the International College of Neuropsychopharmacology 2
    ... Oak Ridge National Laboratory researchers will lead projects that ... hours of computing time on supercomputers located at Oak ... were made through the U.S. Department of Energy (DOE),s ... (INCITE) program. This year, the INCITE program will make ...
    ... National Academy of Sciences ( PNAS ) Editorial Board ... 2009 Cozzarelli Prize, an award that recognizes outstanding contributions to ... Papers selected for the Cozzarelli Prize were chosen from ... in 2009 and represent the six broadly defined classes under ...
    ... than four months since launch, the first calibrated images ... of ,brightness temperature, translate into clear information on global ... our understanding of the water cycle. Launched on ... mission is improving our understanding of Earth,s water cycle ...
    Cached Biology News:2010 DOE INCITE projects allocated at ORNL 22010 DOE INCITE projects allocated at ORNL 32010 DOE INCITE projects allocated at ORNL 4PNAS announces 6 2009 Cozzarelli Prize recipients 2First images from ESA's water mission 2First images from ESA's water mission 3
    Hepatocyte Differentiation Environment...
    Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
    ...
    Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
    Biology Products: